BioAge Labs (BIOA) Accumulated Expenses (2023 - 2026)

BioAge Labs has disclosed Accumulated Expenses across 4 years of filings, most recently posting $8.5 million for Q2 2026.

• In Q2 2026, Accumulated Expenses rose 11.91% year-over-year to $8.5 million; the TTM figure through Jun 2026 stood at $8.5 million (up 11.91% YoY), while the FY2025 annual figure was $8.5 million, down 27.84% from the prior year.
• Accumulated Expenses came in at $8.5 million for Q2 2026 at BioAge Labs, up from $4.8 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $11.8 million in Q4 2024 to a low of $4.8 million in Q1 2026.
• Average Accumulated Expenses over 4 years is $8.0 million, with a median of $7.9 million recorded in 2023.
• Year-over-year, Accumulated Expenses jumped 48.03% in 2024 and slumped 32.18% in 2025.
• Over 4 years, Accumulated Expenses stood at $7.9 million in 2023, then soared by 48.03% to $11.8 million in 2024, then fell by 27.84% to $8.5 million in 2025, then climbed by 0.08% to $8.5 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $8.5 million in Q2 2026, $4.8 million in Q1 2026, and $8.5 million in Q4 2025.